Savigny sur Orge, France

Guy Plassard

This inventor holds 2 USPTO granted patents. Top assignee: Roussel Uclaf. Active years: 1982-1986.


% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Savigny sur Orge, FR (1982)
  • Savigny S/Orge, FR (1986)

Company Filing History:


Years Active: 1982-1986

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Guy Plassard: Innovator in Pharmaceutical Chemistry

Introduction

Guy Plassard is a notable inventor based in Savigny sur Orge, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents, his work has garnered attention for its potential impact on healthcare.

Latest Patents

Plassard's latest patents include innovative compounds such as 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,l-j-k][1]-benzazepin-2-(1 H)-one derivatives. These compounds exhibit remarkable anti-hypertensive and hypotensive activity, along with vasodilatatory effects. Additionally, he has developed trans cyclohept[c,d]indolols, which also demonstrate hypotensive and antihypertensive properties. These inventions highlight his commitment to advancing medical science through innovative chemistry.

Career Highlights

Guy Plassard is currently associated with Roussel Uclaf, a company known for its focus on pharmaceutical research and development. His work at the company has allowed him to explore new avenues in drug development, contributing to the advancement of therapeutic options for patients.

Collaborations

Throughout his career, Plassard has collaborated with esteemed colleagues such as Daniel Frechet and Lucien Nedelec. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical chemistry.

Conclusion

Guy Plassard's contributions to pharmaceutical chemistry through his patents and collaborations underscore his role as a significant innovator in the industry. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…